Full text

Turn on search term navigation

© 2023. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objective:

Cholangiocarcinomas (CC) are rare tumors that develop from the biliary tract and surgery is the gold standard for them. All efforts have been made by surgeons from past to present to obtain R0 resection. The aim of the study was to examine the surgical therapy of CCs, which we have applied various surgical treatments in our clinic in the last three years.

Methods:

Patients whose pathological examination yielded Hiler CC and underwent surgical operation at our clinic between February 2019 and February 2022 were retrospectively evaluated.

Results:

Twenty five patients were found suitable for the study. Nine were male and 16 were female, with a mean age of 61.72±11.12 (minimum-maximum: 29-76) years. The overall morbidity rate in the postoperative period was 52%, and liver failure in the postoperative period was seen in 4 patients. Bile leakage developed in 2 patients. Portal vein thrombosis was detected in 2 patients and surgical site infection was detected in 5 patients. No mortality was seen in the intraoperative and postoperative periods. In the follow-up period, recurrence was observed in 3 patients and mortality was observed in 3 patients.

Conclusion:

Advanced surgical techniques have induced extended indications in surgery and reduced mortality and morbidity ratios, and oncologic outcomes were more acceptable than before. The most significant purpose is to perform R0 resection to maintain adequate remnant liver volume. Such complex surgeries require multidisciplinary treatment in specialized hepatopancreaticobiliary and liver transplant services to optimize surgical and oncological outcomes.

Details

Title
The Surgical Results of Cholangiocarcinomas, Single Center Experience
Author
Osman Aydın  VIAFID ORCID Logo  ; Öter, Volkan  VIAFID ORCID Logo  ; Güven, Alper  VIAFID ORCID Logo  ; Yiğit, Mehmet Özgün  VIAFID ORCID Logo  ; Muhammet Kadri Çolakoğlu  VIAFID ORCID Logo  ; Pişkin, Erol  VIAFID ORCID Logo  ; Erdal Birol Bostancı  VIAFID ORCID Logo 
Pages
152-155
Section
Research
Publication year
2023
Publication date
Jun 2023
Publisher
Galenos Publishing House
ISSN
13059319
e-ISSN
13059327
Source type
Scholarly Journal
Language of publication
Turkish; English
ProQuest document ID
3198178778
Copyright
© 2023. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.